241 related articles for article (PubMed ID: 17519277)
1. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000.
Yee CS; Isenberg DA; Prabu A; Sokoll K; Teh LS; Rahman A; Bruce IN; Griffiths B; Akil M; McHugh N; D'Cruz D; Khamashta MA; Maddison P; Zoma A; Gordon C
Ann Rheum Dis; 2008 Jun; 67(6):873-6. PubMed ID: 17519277
[TBL] [Abstract][Full Text] [Related]
2. Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity.
Yee CS; Farewell V; Isenberg DA; Prabu A; Sokoll K; Teh LS; Rahman A; Bruce IN; Griffiths B; Akil M; McHugh N; D'Cruz D; Khamashta MA; Bowman S; Maddison P; Zoma A; Allen E; Gordon C;
Arthritis Rheum; 2006 Oct; 54(10):3300-5. PubMed ID: 17009266
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally.
Yee CS; Gordon C; Isenberg DA; Griffiths B; Teh LS; Bruce IN; Ahmad Y; Rahman A; Prabu A; Akil M; McHugh N; Edwards CJ; D'Cruz D; Khamashta MA; Farewell VT
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1623-1630. PubMed ID: 33787088
[TBL] [Abstract][Full Text] [Related]
5. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus.
Yee CS; Farewell V; Isenberg DA; Rahman A; Teh LS; Griffiths B; Bruce IN; Ahmad Y; Prabu A; Akil M; McHugh N; D'Cruz D; Khamashta MA; Maddison P; Gordon C
Arthritis Rheum; 2007 Dec; 56(12):4113-9. PubMed ID: 18050213
[TBL] [Abstract][Full Text] [Related]
6. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
[TBL] [Abstract][Full Text] [Related]
8. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility of SLEDAI-2000 and BILAG-2004 scoring systems for assessing renal disease activity in children with lupus nephritis].
Zhou JQ; Jiang H
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):775-9. PubMed ID: 23092572
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.
Fatemi A; Raeisi A; Sayedbonakdar Z; Smiley A
Clin Rheumatol; 2018 Apr; 37(4):955-962. PubMed ID: 29256112
[TBL] [Abstract][Full Text] [Related]
11. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
[TBL] [Abstract][Full Text] [Related]
12. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
Wollaston SJ; Farewell VT; Isenberg DA; Gordon C; Merrill JT; Petri MA; Kalunian KC;
J Rheumatol; 2004 Dec; 31(12):2390-4. PubMed ID: 15570639
[TBL] [Abstract][Full Text] [Related]
13. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus.
Isenberg DA; Rahman A; Allen E; Farewell V; Akil M; Bruce IN; D'Cruz D; Griffiths B; Khamashta M; Maddison P; McHugh N; Snaith M; Teh LS; Yee CS; Zoma A; Gordon C
Rheumatology (Oxford); 2005 Jul; 44(7):902-6. PubMed ID: 15814577
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments As Evaluated by Clinical Investigators or Real-World Clinicians.
Askanase AD; Nguyen SC; Costenbader K; Lim SS; Kamen D; Aranow C; Grossman J; Kapoor TM; Baker-Frost D; Aberle T; Thanou-Stavraki A; Hanrahan LM; Kim M; Merrill JT
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1058-1063. PubMed ID: 28992399
[TBL] [Abstract][Full Text] [Related]
15. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI).
Lattanzi B; Consolaro A; Solari N; Ruperto N; Martini A; Ravelli A
Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S112-7. PubMed ID: 22588739
[No Abstract] [Full Text] [Related]
16. Advances in the assessment of lupus disease activity and damage.
Rao V; Gordon C
Curr Opin Rheumatol; 2014 Sep; 26(5):510-9. PubMed ID: 25010438
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
Brunner HI; Feldman BM; Bombardier C; Silverman ED
Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
[TBL] [Abstract][Full Text] [Related]
18. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus.
Marks SD; Pilkington C; Woo P; Dillon MJ
Rheumatology (Oxford); 2004 Sep; 43(9):1186-9. PubMed ID: 15226518
[TBL] [Abstract][Full Text] [Related]
19. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.
Hay EM; Bacon PA; Gordon C; Isenberg DA; Maddison P; Snaith ML; Symmons DP; Viner N; Zoma A
Q J Med; 1993 Jul; 86(7):447-58. PubMed ID: 8210301
[TBL] [Abstract][Full Text] [Related]
20. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
